S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.83 (+0.20%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.83 (+0.20%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.83 (+0.20%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
S&P 500   3,117.43 (+0.15%)
DOW   27,677.79 (+0.10%)
QQQ   202.83 (+0.20%)
AAPL   265.58 (+1.47%)
FB   199.36 (+0.33%)
MSFT   149.93 (+0.05%)
GOOGL   1,326.96 (+0.61%)
AMZN   1,740.48 (-1.15%)
CGC   18.60 (+1.20%)
NVDA   208.74 (-0.32%)
MU   46.62 (+0.69%)
BABA   200.00 (+3.23%)
GE   10.79 (-1.01%)
TSLA   330.37 (-0.80%)
T   38.19 (+0.24%)
AMD   39.62 (-0.18%)
ACB   2.44 (-1.61%)
F   8.93 (-0.22%)
PRI   134.30 (+0.83%)
NFLX   302.86 (-0.48%)
BAC   33.09 (-0.18%)
GILD   65.93 (-1.23%)
DIS   147.44 (-0.57%)
Log in

NASDAQ:SWAV - Shockwave Medical Stock Price, Forecast & News

$39.58
-0.14 (-0.35 %)
(As of 12/5/2019 04:00 PM ET)
Today's Range
$38.62
Now: $39.58
$40.09
50-Day Range
$31.28
MA: $35.57
$39.71
52-Week Range
$24.58
Now: $39.58
$68.39
Volume556,171 shs
Average Volume443,871 shs
Market Capitalization$1.12 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
ShockWave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters or treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:SWAV
CUSIPN/A
CIKN/A
Phone510-279-4262

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees162
Market Cap$1.12 billion
Next Earnings Date2/6/2020 (Estimated)
OptionableNot Optionable

Receive SWAV News and Ratings via Email

Sign-up to receive the latest news and ratings for SWAV and its competitors with MarketBeat's FREE daily newsletter.


Shockwave Medical (NASDAQ:SWAV) Frequently Asked Questions

What is Shockwave Medical's stock symbol?

Shockwave Medical trades on the NASDAQ under the ticker symbol "SWAV."

How were Shockwave Medical's earnings last quarter?

Shockwave Medical Inc (NASDAQ:SWAV) posted its quarterly earnings data on Thursday, November, 7th. The company reported ($0.46) EPS for the quarter, beating the Zacks' consensus estimate of ($0.51) by $0.05. The business earned $11.33 million during the quarter, compared to analysts' expectations of $10.42 million. The business's revenue was up 214.7% compared to the same quarter last year. View Shockwave Medical's Earnings History.

When is Shockwave Medical's next earnings date?

Shockwave Medical is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for Shockwave Medical.

What guidance has Shockwave Medical issued on next quarter's earnings?

Shockwave Medical updated its FY 2019 After-Hours earnings guidance on Monday, November, 25th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $$41-42 million, compared to the consensus revenue estimate of $$40.09 million.

What price target have analysts set for SWAV?

6 Wall Street analysts have issued 1 year target prices for Shockwave Medical's stock. Their forecasts range from $32.00 to $49.00. On average, they expect Shockwave Medical's stock price to reach $40.20 in the next twelve months. This suggests a possible upside of 1.6% from the stock's current price. View Analyst Price Targets for Shockwave Medical.

What is the consensus analysts' recommendation for Shockwave Medical?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Shockwave Medical in the last year. There are currently 4 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Shockwave Medical.

Has Shockwave Medical been receiving favorable news coverage?

News articles about SWAV stock have trended somewhat negative on Thursday, according to InfoTrie Sentiment. The research group rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Shockwave Medical earned a media sentiment score of -1.6 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View News Stories for Shockwave Medical.

Who are some of Shockwave Medical's key competitors?

What other stocks do shareholders of Shockwave Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Shockwave Medical investors own include NVIDIA (NVDA), Alibaba Group (BABA), salesforce.com (CRM), Home Depot (HD), Twilio (TWLO), Paypal (PYPL), Guardant Health (GH), Marvell Technology Group (MRVL), QUALCOMM (QCOM) and Trade Desk (TTD).

Who are Shockwave Medical's key executives?

Shockwave Medical's management team includes the folowing people:
  • Mr. Douglas E. Godshall, CEO, Pres & Director (Age 54)
  • Mr. Daniel Puckett, CFO & Sec. (Age 55)
  • Mr. Isaac Zacharias, Chief Commercial Officer (Age 44)
  • Mr. Daniel Hawkins, Founder and Sr. Advisor (Age 52)
  • Mr. John M. Adams, Co-Founder and Technical Advisor (Age 72)

When did Shockwave Medical IPO?

(SWAV) raised $75 million in an initial public offering (IPO) on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch acted as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

Who are Shockwave Medical's major shareholders?

Shockwave Medical's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Millennium Management LLC (0.50%), State Street Corp (0.41%), Voloridge Investment Management LLC (0.19%), Segantii Capital Management Ltd (0.16%), Lisanti Capital Growth LLC (0.11%) and WCM Investment Management LLC (0.07%). Company insiders that own Shockwave Medical stock include Antoine Papiernik, Dan Puckett, Douglas Evan Godshall, Frederic H Moll, Isaac Zacharias and James E Flynn. View Institutional Ownership Trends for Shockwave Medical.

Which major investors are selling Shockwave Medical stock?

SWAV stock was sold by a variety of institutional investors in the last quarter, including Lisanti Capital Growth LLC and Barclays PLC. Company insiders that have sold Shockwave Medical company stock in the last year include Antoine Papiernik, Dan Puckett, Douglas Evan Godshall, Frederic H Moll and Isaac Zacharias. View Insider Buying and Selling for Shockwave Medical.

Which major investors are buying Shockwave Medical stock?

SWAV stock was acquired by a variety of institutional investors in the last quarter, including Millennium Management LLC, Voloridge Investment Management LLC, Segantii Capital Management Ltd, WCM Investment Management LLC, SG Americas Securities LLC, State Street Corp, Metropolitan Life Insurance Co NY and Benjamin F. Edwards & Company Inc.. View Insider Buying and Selling for Shockwave Medical.

How do I buy shares of Shockwave Medical?

Shares of SWAV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Shockwave Medical's stock price today?

One share of SWAV stock can currently be purchased for approximately $39.58.

How big of a company is Shockwave Medical?

Shockwave Medical has a market capitalization of $1.12 billion. Shockwave Medical employs 162 workers across the globe.View Additional Information About Shockwave Medical.

What is Shockwave Medical's official website?

The official website for Shockwave Medical is http://www.shockwavemedical.com/.

How can I contact Shockwave Medical?

Shockwave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The company can be reached via phone at 510-279-4262 or via email at [email protected]


MarketBeat Community Rating for Shockwave Medical (NASDAQ SWAV)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  40 (Vote Outperform)
Underperform Votes:  49 (Vote Underperform)
Total Votes:  89
MarketBeat's community ratings are surveys of what our community members think about Shockwave Medical and other stocks. Vote "Outperform" if you believe SWAV will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SWAV will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/5/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel